HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

László Vécsei Selected Research

Neoplasms (Cancer)

12/2020Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.
11/2020Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


László Vécsei Research Topics

Disease

50Migraine Disorders (Migraine)
01/2024 - 04/2004
35Parkinson Disease (Parkinson's Disease)
01/2022 - 07/2003
34Multiple Sclerosis
03/2023 - 05/2006
22Pain (Aches)
11/2023 - 01/2009
22Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 07/2005
18Huntington Disease (Huntington's Disease)
09/2020 - 09/2002
16Headache (Headaches)
09/2022 - 09/2006
15Neuroinflammatory Diseases
04/2023 - 11/2009
14Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2005
11Inflammation (Inflammations)
02/2023 - 08/2010
10Mitochondrial Diseases (Mitochondrial Disease)
01/2024 - 06/2007
10Nervous System Diseases (Neurological Disorders)
01/2021 - 07/2005
10Epilepsy (Aura)
01/2021 - 07/2005
9Schizophrenia (Dementia Praecox)
01/2024 - 05/2017
9Ischemic Stroke
12/2021 - 05/2008
8Stroke (Strokes)
10/2021 - 07/2005
8Dyskinesias (Dyskinesia)
11/2016 - 01/2004
7Mental Disorders (Mental Disorder)
10/2023 - 02/2012
7Relapsing-Remitting Multiple Sclerosis
05/2022 - 05/2006
6Neurogenic Inflammation
12/2022 - 04/2004
6Disease Progression
01/2022 - 03/2013
6Dementia (Dementias)
01/2020 - 11/2013
5Brain Ischemia (Cerebral Ischemia)
10/2021 - 09/2003
5Autoimmune Diseases (Autoimmune Disease)
12/2020 - 01/2013
4Demyelinating Diseases (Demyelinating Disease)
03/2023 - 05/2011
4Cognitive Dysfunction
07/2021 - 01/2013
4Atrophy
07/2016 - 07/2003
3Asphyxia (Suffocation)
09/2023 - 12/2017
3Hypothermia
09/2023 - 12/2015
3Body Weight (Weight, Body)
03/2023 - 01/2015
3Chronic Pain
02/2023 - 07/2003
3Hypersensitivity (Allergy)
11/2022 - 05/2008
3Chronic Progressive Multiple Sclerosis
01/2022 - 03/2009
3Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
03/2020 - 11/2016
3Pathologic Processes
08/2015 - 04/2011
3Ischemia
09/2011 - 06/2007
2Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
09/2023 - 05/2021
2Immune System Diseases (Immune Disorders)
03/2022 - 11/2017
2Edema (Dropsy)
12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

50KynurenineIBA
01/2024 - 06/2007
36Kynurenic Acid (Kynurenate)IBA
11/2023 - 09/2003
23Tryptophan (L-Tryptophan)FDA Link
09/2023 - 02/2010
21Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2009
20Glutamic Acid (Glutamate)FDA Link
04/2023 - 02/2009
14Calcitonin Gene-Related PeptideIBA
06/2023 - 01/2009
14N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021 - 04/2004
13Levodopa (L Dopa)FDA LinkGeneric
01/2020 - 01/2005
12NeuropeptidesIBA
11/2023 - 07/2003
12EnzymesIBA
12/2021 - 07/2003
11Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
11/2023 - 02/2012
9CytokinesIBA
02/2023 - 02/2012
8Neuroprotective AgentsIBA
01/2021 - 09/2003
8Proteins (Proteins, Gene)FDA Link
03/2020 - 06/2005
8Glutamate Receptors (Glutamate Receptor)IBA
09/2019 - 09/2002
8N-Methylaspartate (NMDA)IBA
01/2018 - 06/2007
7Nitroglycerin (Dynamite)FDA LinkGeneric
11/2017 - 11/2006
6Excitatory Amino Acid AntagonistsIBA
11/2023 - 11/2013
6Tryptamines (Triptans)IBA
06/2023 - 06/2015
6Monoclonal AntibodiesIBA
06/2023 - 03/2013
6Serotonin (5 Hydroxytryptamine)IBA
03/2023 - 11/2014
6Messenger RNA (mRNA)IBA
09/2022 - 11/2007
5Peptides (Polypeptides)IBA
11/2023 - 08/2010
5Type A Botulinum Toxins (Botox)FDA Link
02/2023 - 03/2012
5Monoamine Oxidase (MAO)IBA
01/2022 - 05/2013
5Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2017 - 04/2004
4Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2023 - 12/2016
4EndocannabinoidsIBA
02/2023 - 08/2016
4Substance PIBA
12/2022 - 03/2012
4AntibodiesIBA
01/2022 - 05/2006
4Selegiline (E250)FDA LinkGeneric
01/2022 - 01/2004
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2012
4SZR 72IBA
01/2021 - 12/2015
4Formaldehyde (Formol)FDA Link
01/2018 - 01/2015
4Adenosine Triphosphate (ATP)IBA
11/2013 - 06/2007
3Analgesics (Analgesic Drugs)IBA
11/2023 - 06/2015
3Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
06/2023 - 01/2015
3anthranilic acid (anthranilate)IBA
03/2023 - 06/2020
3Estradiol (Delestrogen)FDA LinkGeneric
12/2022 - 11/2006
3Alemtuzumab (Campath)FDA Link
11/2022 - 03/2013
3MelatoninIBA
11/2022 - 06/2020
3teriflunomideIBA
05/2022 - 03/2015
3Mitochondrial DNA (mtDNA)IBA
01/2022 - 02/2017
3Neurotransmitter Agents (Neurotransmitter)IBA
12/2021 - 03/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 03/2009
3Peroxidase (Myeloperoxidase)IBA
01/2021 - 08/2012
3Dopamine (Intropin)FDA LinkGeneric
11/2018 - 01/2005
3NeurotoxinsIBA
02/2017 - 09/2002
3Carbidopa (Lodosyn)FDA LinkGeneric
01/2017 - 03/2014
2OrexinsIBA
02/2024 - 08/2015
2Ion Channels (Ion Channel)IBA
11/2023 - 02/2023
2IronIBA
08/2023 - 01/2022
2CuprizoneIBA
03/2023 - 02/2021
2xanthurenic acidIBA
03/2023 - 06/2020
2SolutionsIBA
02/2023 - 01/2015
2Complement System Proteins (Complement)IBA
02/2023 - 10/2020
2ChromatinIBA
01/2022 - 06/2005
2Memantine (Namenda)FDA Link
01/2022 - 01/2016
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 03/2012
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2022 - 01/2019

Therapy/Procedure

53Therapeutics
11/2023 - 07/2003